Implication of follow-up planning and characteristics of DLBCL achieving CR after first-line therapy

Harumi Kato

Presentation information

Oral Session

Oral Session 2-8D DLBCL: Clinical practice

Sat. Oct 13, 2018 4:00 PM - 5:00 PM No.8 (Osaka International Convention Center, 10F 1002)

Chair: Ken Ohmachi (Tokai University School of Medicine, Demartment of Internal Medicine, Dirision of Hematology/ Oncology, Japan)

[OS2-8D-6] Implication of follow-up planning and characteristics of DLBCL achieving CR after first-line therapy

Harumi Kato¹, Toko Saito¹, Masamitsu Yanada¹, Seiichi Kato², Hirofumi Taji¹, Yasushi Yatabe², Kazuhito Yamamoto¹ (1.Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, 2.Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital)

Abstract password authentication.
Password is written on a program and abstract book.